应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ADPT Adaptive Biotechnologies Corp
交易中 11-18 15:24:34 EST
4.84
-0.24
-4.82%
最高
5.10
最低
4.77
成交量
69.31万
今开
4.98
昨收
5.08
日振幅
6.59%
总市值
7.14亿
流通市值
4.25亿
总股本
1.48亿
成交额
341.98万
换手率
0.79%
流通股本
8,798万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Adaptive Biotechnologies Corporation盘中异动 下午盘快速下跌5.12%
市场透视 · 03:19
Adaptive Biotechnologies Corporation盘中异动 下午盘快速下跌5.12%
Adaptive Biotechnologies Corporation2024财年第三财季实现净利润-32.07百万美元,同比增加36.24%
市场透视 · 11-17 00:03
Adaptive Biotechnologies Corporation2024财年第三财季实现净利润-32.07百万美元,同比增加36.24%
Adaptive Biotechnologies Corporation盘中异动 股价大跌5.04%
市场透视 · 11-15
Adaptive Biotechnologies Corporation盘中异动 股价大跌5.04%
Adaptive Biotechnologies Corporation盘中异动 早盘快速跳水5.24%报6.15美元
市场透视 · 11-13
Adaptive Biotechnologies Corporation盘中异动 早盘快速跳水5.24%报6.15美元
异动解读 | 生物技术公司Adaptive Biotechnologies盘中大涨9.28%
异动解读 · 11-11
异动解读 | 生物技术公司Adaptive Biotechnologies盘中大涨9.28%
Adaptive Biotechnologies Corporation盘中异动 早盘股价大涨6.36%报6.19美元
市场透视 · 11-11
Adaptive Biotechnologies Corporation盘中异动 早盘股价大涨6.36%报6.19美元
美国研究综述-Akamai Technologies、Bill Holdings、Veeva Systems
路透中文 · 11-11
美国研究综述-Akamai Technologies、Bill Holdings、Veeva Systems
异动解读 | Adaptive Biotechnologies公布佳绩引发股价大涨
异动解读 · 11-09
异动解读 | Adaptive Biotechnologies公布佳绩引发股价大涨
Adaptive Biotechnologies 公司报告截至 9 月 30 日的季度业绩 - 收益摘要
路透中文 · 11-09
Adaptive Biotechnologies 公司报告截至 9 月 30 日的季度业绩 - 收益摘要
Adaptive Biotechnologies Corporation盘中异动 快速拉升8.77%报6.12美元
市场透视 · 11-08
Adaptive Biotechnologies Corporation盘中异动 快速拉升8.77%报6.12美元
Adaptive Biotechnologies Corporation盘中异动 下午盘股价大涨5.13%
市场透视 · 11-06
Adaptive Biotechnologies Corporation盘中异动 下午盘股价大涨5.13%
Adaptive Biotechnologies Corporation盘中异动 早盘股价大涨5.17%
市场透视 · 11-01
Adaptive Biotechnologies Corporation盘中异动 早盘股价大涨5.17%
Adaptive Biotechnologies Corporation盘中异动 早盘大幅拉升5.06%报4.68美元
市场透视 · 10-28
Adaptive Biotechnologies Corporation盘中异动 早盘大幅拉升5.06%报4.68美元
Adaptive Biotechnologies Corporation盘中异动 临近收盘快速下挫5.08%
市场透视 · 10-25
Adaptive Biotechnologies Corporation盘中异动 临近收盘快速下挫5.08%
Adaptive Biotechnologies Corporation盘中异动 早盘快速下跌5.02%
市场透视 · 10-21
Adaptive Biotechnologies Corporation盘中异动 早盘快速下跌5.02%
Adaptive Biotechnologies Corporation盘中异动 临近收盘股价大跌5.14%
市场透视 · 10-10
Adaptive Biotechnologies Corporation盘中异动 临近收盘股价大跌5.14%
Adaptive Biotechnologies Corporation盘中异动 快速拉升5.04%报5.32美元
市场透视 · 10-05
Adaptive Biotechnologies Corporation盘中异动 快速拉升5.04%报5.32美元
Adaptive Biotechnologies Corporation盘中异动 下午盘大幅下挫5.37%
市场透视 · 10-02
Adaptive Biotechnologies Corporation盘中异动 下午盘大幅下挫5.37%
Adaptive Biotechnologies Corporation盘中异动 快速拉升6.00%报5.30美元
市场透视 · 09-30
Adaptive Biotechnologies Corporation盘中异动 快速拉升6.00%报5.30美元
Adaptive Biotechnologies Corporation盘中异动 早盘股价大涨5.50%
市场透视 · 09-26
Adaptive Biotechnologies Corporation盘中异动 早盘股价大涨5.50%
公司概况
公司名称:
Adaptive Biotechnologies Corp
所属市场:
NASDAQ
上市日期:
--
主营业务:
Adaptive Biotechnologies Corporation于2009年9月8日在华盛顿州注册成立。他们通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,从而推进免疫驱动医学领域。他们认为适应性免疫系统是大多数疾病中自然界最精细调整的诊断和治疗方法,但无法对其进行解码,这阻碍了医学界充分利用其能力。他们的免疫医学平台采用专有技术来阅读患者免疫系统的各种遗传密码,并准确了解其如何检测和治疗患者的疾病。他们在动态临床免疫组学数据库中捕获这些见解,该数据库以计算生物学和机器学习为基础,并利用它们开发和商业化他们为每个患者定制的临床产品和服务。
发行价格:
--
{"stockData":{"symbol":"ADPT","market":"US","secType":"STK","nameCN":"Adaptive Biotechnologies Corp","latestPrice":4.835,"timestamp":1731961470562,"preClose":5.08,"halted":0,"volume":693086,"delay":0,"floatShares":87976455,"shares":147579486,"eps":-1.337671,"marketStatus":"交易中","marketStatusCode":2,"change":-0.245,"latestTime":"11-18 15:24:34 EST","open":4.98,"high":5.1,"low":4.765,"amount":3419788.9007280003,"amplitude":0.065945,"askPrice":4.84,"askSize":582,"bidPrice":4.83,"bidSize":536,"shortable":3,"etf":0,"ttmEps":-1.337671,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1731963600000},"adr":0,"listingDate":1561608000000,"adjPreClose":5.08,"preHourTrading":{"tag":"盘前","latestPrice":5,"preClose":5.08,"latestTime":"09:29 EST","volume":1371,"amount":6850.0498674,"timestamp":1731940199999},"postHourTrading":{"tag":"盘后","latestPrice":5.19,"preClose":5.08,"latestTime":"19:29 EST","volume":16791,"amount":85350.02,"timestamp":1731716979189},"volumeRatio":0.5848,"impliedVol":0.612,"impliedVolPercentile":0.1633},"requestUrl":"/m/hq/s/ADPT/wiki","defaultTab":"wiki","newsList":[{"id":"2484600344","title":"Adaptive Biotechnologies Corporation盘中异动 下午盘快速下跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484600344","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484600344?lang=zh_cn&edition=full","pubTime":"2024-11-19 03:19","pubTimestamp":1731957586,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日03时19分,Adaptive Biotechnologies Corporation股票出现波动,股价快速跳水5.12%。截至发稿,该股报4.82美元/股,成交量54.4125万股,换手率0.37%,振幅5.12%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体跌幅为0.01%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119031946a243a4b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119031946a243a4b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"gpt_icon":0},{"id":"2484548963","title":"Adaptive Biotechnologies Corporation2024财年第三财季实现净利润-32.07百万美元,同比增加36.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484548963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484548963?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:03","pubTimestamp":1731773006,"startTime":"0","endTime":"0","summary":"11月17日,Adaptive Biotechnologies Corporation公布财报,公告显示公司2024财年第三财季净利润为-32.07百万美元,同比增加36.24%;其中营业收入为46.44百万美元,同比增加22.47%,每股基本收益为-0.22美元。从资产负债表来看,Adaptive Biotechnologies Corporation总负债3.35亿美元,其中短期债务10.02百万美元,资产负债比为1.67,流动比率为0.04。机构评级:截至2024年11月17日,当前有5家机构对Adaptive Biotechnologies Corporation目标价做出预测,其中目标均价为7.50美元,其中最低目标价为5.50美元,最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000439abc79100&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000439abc79100&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT"],"gpt_icon":0},{"id":"2483502331","title":"Adaptive Biotechnologies Corporation盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483502331","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483502331?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:05","pubTimestamp":1731614743,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时05分,Adaptive Biotechnologies Corporation股票出现异动,股价大幅下跌5.04%。截至发稿,该股报5.56美元/股,成交量51.2198万股,换手率0.35%,振幅6.75%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体跌幅为1.31%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115040544abc201b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115040544abc201b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"gpt_icon":0},{"id":"2483805190","title":"Adaptive Biotechnologies Corporation盘中异动 早盘快速跳水5.24%报6.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483805190","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483805190?lang=zh_cn&edition=full","pubTime":"2024-11-13 00:00","pubTimestamp":1731427211,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日00时00分,Adaptive Biotechnologies Corporation股票出现波动,股价急速跳水5.24%。截至发稿,该股报6.15美元/股,成交量16.3815万股,换手率0.11%,振幅4.93%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体跌幅为0.51%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113000011abba78e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113000011abba78e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"gpt_icon":0},{"id":"1170644948","title":"异动解读 | 生物技术公司Adaptive Biotechnologies盘中大涨9.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=1170644948","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170644948?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:42","pubTimestamp":1731336149,"startTime":"0","endTime":"0","summary":"2024年11月11日,生物技术公司Adaptive Biotechnologies Corporation盘中股价出现大幅上涨,最高涨幅达9.28%。据报道,截至收盘该公司股价报收于6.19美元,成交量2.7134万股。Adaptive Biotechnologies是一家利用免疫系统生物学改变疾病诊断和治疗的公司。其产品clonoSEQ可用于检测和监测多种癌症患者的微小残留病灶。资料显示,该公司最新季度实现营收4644万美元,净亏损3207万美元。尽管并无具体新闻直接解释Adaptive Biotechnologies当日股价大涨的原因,但分析人士猜测,这可能与公司最新的财报数据或产品进展情况有关。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ADPT"],"gpt_icon":0},{"id":"2482078000","title":"Adaptive Biotechnologies Corporation盘中异动 早盘股价大涨6.36%报6.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482078000","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482078000?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:31","pubTimestamp":1731335518,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时31分,Adaptive Biotechnologies Corporation股票出现波动,股价急速上涨6.36%。截至发稿,该股报6.19美元/股,成交量2.7134万股,换手率0.02%,振幅0.17%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体跌幅为0.05%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122315998e41c4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122315998e41c4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2482201282","title":"美国研究综述-Akamai Technologies、Bill Holdings、Veeva Systems","url":"https://stock-news.laohu8.com/highlight/detail?id=2482201282","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482201282?lang=zh_cn&edition=full","pubTime":"2024-11-11 15:08","pubTimestamp":1731308918,"startTime":"0","endTime":"0","summary":"美国研究综述-Akamai Technologies、Bill Holdings、Veeva Systems路透11月11日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价,其中包括 Akamai Technologies、Bill Holdings 和 Veeva Systems。要闻 * Akamai Technologies Inc AKAM.O:汇丰银行将目标价从107美元上调至121美元 * Bill Holdings Inc BILL.N:杰富瑞将目标价从65美元上调至92美元 * Charles River Laboratories International CRL.N:TD Cowen将目标价从203美元上调至227美元 * Veeva Systems Inc VEEV.N:Jefferies 将目标价从 240 美元上调至 280 美元 * Xeris Biopharma Holdings Inc XERS.O:Piper Sandler将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241111:nL4S3MI0GL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRK","AKAM","CELH","AFL","ATMU","EL","EXAS","LU0690374615.EUR","AMP","CBT","EVH","CRBG","VEEV","CIM","DKNG","BK4167","BRX","CPAY","BK4530","BK4528","CUZ","BK4565","CYBR","LU0511384066.AUD","CNA","ALRM","ACT","CRL","CTKB","APA","ADPT","LU2552382215.SGD","ENPH","CERT","BOW","TKNO","BK4077","BK4539","BILL","ANIP","COTY","DOCS","BHF","CUBE","BAX","BMBL","EXR","CACI"],"gpt_icon":1},{"id":"1137264353","title":"异动解读 | Adaptive Biotechnologies公布佳绩引发股价大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1137264353","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137264353?lang=zh_cn&edition=full","pubTime":"2024-11-09 05:10","pubTimestamp":1731100250,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies Corp昨日盘中股价大涨8.77%,引发市场热议。此前该公司发布的2024年第三季度财报数据超出市场预期,成为引发股价大涨的主因。数据显示,Adaptive Biotechnologies第三季度每股亏损22美分,好于分析师预期的29美分亏损;营收同比增长22.5%至4644万美元,也高于分析师预期的4021万美元。公司主打产品clonoSEQ是获FDA授权用于检测和监测多发性骨髓瘤等多种淋巴癌的临床诊断产品。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ADPT"],"gpt_icon":0},{"id":"2482555144","title":"Adaptive Biotechnologies 公司报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2482555144","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482555144?lang=zh_cn&edition=full","pubTime":"2024-11-09 05:07","pubTimestamp":1731100024,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies 公司报告截至 9 月 30 日的季度业绩 - 收益摘要Adaptive Biotechnologies Corp ADPT.OQ报告,截至9月30日的季度调整后每股亏损22美分,高于去年同期的每股-35美分。八位分析师对该季度的平均预期是每股亏损 29 美分。Adaptive Biotechnologies 公司公布的本季度每股收益为亏损 22 美分。该公司当季亏损 3205 万美元。Adaptive Biotechnologies Corp本季度股价上涨了10.0%,今年迄今为止上涨了14.9%。华尔街对 Adaptive Biotechnologies Corp 的 12 个月目标价中位数为 7.00 美元。如有任何其他问题或反馈,请联系 RefinitivNewsSupport@thomsonreuters.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4S3MF2L8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2481101591","title":"Adaptive Biotechnologies Corporation盘中异动 快速拉升8.77%报6.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481101591?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:34","pubTimestamp":1731076442,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时34分,Adaptive Biotechnologies Corporation股票出现异动,股价大幅上涨8.77%。截至发稿,该股报6.12美元/股,成交量6.5757万股,换手率0.04%,振幅7.90%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体涨幅为0.31%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822340295bdef6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822340295bdef6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2481370996","title":"Adaptive Biotechnologies Corporation盘中异动 下午盘股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481370996","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481370996?lang=zh_cn&edition=full","pubTime":"2024-11-06 03:32","pubTimestamp":1730835129,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日03时32分,Adaptive Biotechnologies Corporation股票出现异动,股价大幅上涨5.13%。截至发稿,该股报5.53美元/股,成交量44.2136万股,换手率0.30%,振幅8.08%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体涨幅为1.52%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106033209a219449e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106033209a219449e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2480880777","title":"Adaptive Biotechnologies Corporation盘中异动 早盘股价大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480880777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480880777?lang=zh_cn&edition=full","pubTime":"2024-11-01 23:04","pubTimestamp":1730473477,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日23时04分,Adaptive Biotechnologies Corporation股票出现异动,股价急速拉升5.17%。截至发稿,该股报5.09美元/股,成交量14.6423万股,换手率0.10%,振幅4.96%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体涨幅为0.46%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110123043798e400a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110123043798e400a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2478482748","title":"Adaptive Biotechnologies Corporation盘中异动 早盘大幅拉升5.06%报4.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478482748","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478482748?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:29","pubTimestamp":1730125745,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时29分,Adaptive Biotechnologies Corporation股票出现异动,股价快速拉升5.06%。截至发稿,该股报4.68美元/股,成交量16.5889万股,换手率0.11%,振幅4.29%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体涨幅为0.66%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028222905ab7be41c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028222905ab7be41c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"gpt_icon":0},{"id":"2478662405","title":"Adaptive Biotechnologies Corporation盘中异动 临近收盘快速下挫5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478662405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478662405?lang=zh_cn&edition=full","pubTime":"2024-10-25 03:40","pubTimestamp":1729798803,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日03时40分,Adaptive Biotechnologies Corporation股票出现异动,股价大幅跳水5.08%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体跌幅为0.45%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025034004971a2227&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025034004971a2227&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"gpt_icon":0},{"id":"2477486476","title":"Adaptive Biotechnologies Corporation盘中异动 早盘快速下跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477486476","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477486476?lang=zh_cn&edition=full","pubTime":"2024-10-21 22:26","pubTimestamp":1729520761,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日22时26分,Adaptive Biotechnologies Corporation股票出现波动,股价急速跳水5.02%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体跌幅为0.46%。其相关个股中,Genprex, Inc.、Biovie Inc.、Gri Bio, Inc.涨幅较大,Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃,换手率分别为3621.61%、2470.52%、960.87%,振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 ,振幅分别为226.88%、157.02%、116.08%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102122260198e3d8cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102122260198e3d8cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2474206084","title":"Adaptive Biotechnologies Corporation盘中异动 临近收盘股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474206084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474206084?lang=zh_cn&edition=full","pubTime":"2024-10-10 03:38","pubTimestamp":1728502694,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日03时38分,Adaptive Biotechnologies Corporation股票出现异动,股价大幅下跌5.14%。截至发稿,该股报4.98美元/股,成交量39.0656万股,换手率0.26%,振幅6.07%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体跌幅为0.11%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010033815ab68e72b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010033815ab68e72b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"gpt_icon":0},{"id":"2473993479","title":"Adaptive Biotechnologies Corporation盘中异动 快速拉升5.04%报5.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473993479","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473993479?lang=zh_cn&edition=full","pubTime":"2024-10-05 01:57","pubTimestamp":1728064668,"startTime":"0","endTime":"0","summary":"北京时间2024年10月05日01时57分,Adaptive Biotechnologies Corporation股票出现波动,股价急速上涨5.04%。截至发稿,该股报5.32美元/股,成交量33.6757万股,换手率0.23%,振幅5.24%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体跌幅为0.20%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410050157499719e6e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410050157499719e6e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2472042123","title":"Adaptive Biotechnologies Corporation盘中异动 下午盘大幅下挫5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472042123","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472042123?lang=zh_cn&edition=full","pubTime":"2024-10-02 01:13","pubTimestamp":1727802811,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日01时13分,Adaptive Biotechnologies Corporation股票出现异动,股价急速下挫5.37%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体跌幅为0.03%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241002011331a1dde25a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241002011331a1dde25a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2471385267","title":"Adaptive Biotechnologies Corporation盘中异动 快速拉升6.00%报5.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471385267","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471385267?lang=zh_cn&edition=full","pubTime":"2024-09-30 21:51","pubTimestamp":1727704312,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日21时51分,Adaptive Biotechnologies Corporation股票出现异动,股价大幅上涨6.00%。截至发稿,该股报5.30美元/股,成交量5.7953万股,换手率0.04%,振幅5.60%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体跌幅为0.30%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409302151529719d9ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409302151529719d9ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"gpt_icon":0},{"id":"2470873159","title":"Adaptive Biotechnologies Corporation盘中异动 早盘股价大涨5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470873159","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470873159?lang=zh_cn&edition=full","pubTime":"2024-09-26 21:32","pubTimestamp":1727357530,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日21时32分,Adaptive Biotechnologies Corporation股票出现波动,股价大幅拉升5.50%。截至发稿,该股报4.22美元/股,成交量5.0044万股,换手率0.03%,振幅2.50%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中,整体涨幅为0.39%。Adaptive Biotechnologies Corporation公司简介:Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926213210a1dcc10e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926213210a1dcc10e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.adaptivebiotech.com","stockEarnings":[{"period":"1week","weight":-0.1271},{"period":"1month","weight":0.0583},{"period":"3month","weight":0.0518},{"period":"6month","weight":0.4072},{"period":"1year","weight":0.2605},{"period":"ytd","weight":0.0367}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Adaptive Biotechnologies Corporation于2009年9月8日在华盛顿州注册成立。他们通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗,从而推进免疫驱动医学领域。他们认为适应性免疫系统是大多数疾病中自然界最精细调整的诊断和治疗方法,但无法对其进行解码,这阻碍了医学界充分利用其能力。他们的免疫医学平台采用专有技术来阅读患者免疫系统的各种遗传密码,并准确了解其如何检测和治疗患者的疾病。他们在动态临床免疫组学数据库中捕获这些见解,该数据库以计算生物学和机器学习为基础,并利用它们开发和商业化他们为每个患者定制的临床产品和服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.095709},{"month":2,"riseRate":0.4,"avgChangeRate":-0.03418},{"month":3,"riseRate":0.2,"avgChangeRate":-0.104809},{"month":4,"riseRate":0.4,"avgChangeRate":-0.119052},{"month":5,"riseRate":0.4,"avgChangeRate":0.071471},{"month":6,"riseRate":0.8,"avgChangeRate":0.075735},{"month":7,"riseRate":0.5,"avgChangeRate":0.018955},{"month":8,"riseRate":0.5,"avgChangeRate":0.038941},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.099197},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.062214},{"month":11,"riseRate":0.666667,"avgChangeRate":0.005852},{"month":12,"riseRate":0.8,"avgChangeRate":0.07821}],"exchange":"NASDAQ","name":"Adaptive Biotechnologies Corp","nameEN":"Adaptive Biotechnologies Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Adaptive Biotechnologies Corp(ADPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Adaptive Biotechnologies Corp(ADPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Adaptive Biotechnologies Corp,ADPT,Adaptive Biotechnologies Corp股票,Adaptive Biotechnologies Corp股票老虎,Adaptive Biotechnologies Corp股票老虎国际,Adaptive Biotechnologies Corp行情,Adaptive Biotechnologies Corp股票行情,Adaptive Biotechnologies Corp股价,Adaptive Biotechnologies Corp股市,Adaptive Biotechnologies Corp股票价格,Adaptive Biotechnologies Corp股票交易,Adaptive Biotechnologies Corp股票购买,Adaptive Biotechnologies Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Adaptive Biotechnologies Corp(ADPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Adaptive Biotechnologies Corp(ADPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}